Daily Stock Opinions and Ratings

Latest Stock Buy or Sell? Make More Informed Decisions!

Today, Editor commented about whether MRNA-Q are stocks to buy or sell.

Page 1/1

COMMENT

As mentioned in our May report to Stockchase subscribers, Moderna (with NIH) began Phase 1 testing for a vaccine back in March. If the drug pasts future tests, Moderna and Swiss drugmaker, Lonza, will produce the drug together. Monday’s news puts Moderna as the frontrunner in the vaccine race and lifted its stock 27% to 84% year-to-date.

Most Recent Experts

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Colin Stewart

JC Clark Investments Ltd.

Stockchase Insights

5i Research

Jim Cramer - Mad Money

CNBC

Bill Harris, CFA

Avenue Investment Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Latest Stock Buy or Sell? Make More Informed Decisions!

Moderna(MRNA-Q)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals